AZD4547 ratriptan PubMed Central PMCID: PMC4275380

PubMed Central PMCID: PMC4275380

and HT-29 (colon) cells revealed similar LD50 values for the two compounds

3H)-pyrimidinedione

It increases H3K4 methylation selectively at genomic regions bound by LSD1

it can be used in edible

AZD4547 ratriptan PubMed Central PMCID: PMC4275380AZD4547 is an orally bioavailable inhibitor of the fibroblast growth factor receptor (FGFR) with potential antineoplastic activity. FGFR inhibitor AZD4547 binds to and inhibits FGFR, which may result in the inhibition of FGFR related signal transduction pathways, and, so, the inhibition of tumor cell proliferation and tumor cell death. FGFR, up regulated in many tumor cell types, is a receptor tyrosine kinase essential to tumor cellular proliferation,